System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jessica Zucman-Rossi

Hepatology — Assistance Publique - Hôpitaux de Paris, France

LeadR Profile

Jessica Zucman-Rossi Assistance Publique - Hôpitaux de Paris France
1 911 ScienceLeadR Reputation 1911

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Oncology - Gastroenterology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Education and key qualifications 2009 Professor of Medicine in Oncology Comité National Universitaire 2018 Accreditation as research director (HDR), Population Genetics Université Paris Diderot, France 1994 PhD in fundamental bases of oncogenesis Curie Institute, Gilles Thomas laboratory, Paris 1994 Medical specialty: Internal Medicine Curie Institute, Gilles Thomas laboratory 1987-1994 Residency in Internal Medicine and Oncology, Paris • Current position(s) Since 2019 Director, Centre de recherche des Cordeliers, Paris Since 2009 Professor, Université Paris Cité, Oncology, Paris Since 2009 Praticienne Hospitalière, APHP, HEGP Hospital, Paris Since 2007 Team leader, Functional genomics of solid tumors, Paris Since 2022 Member of the National deontology college at the French Ministry of Research Since 2025 Member of the HCERES college Since 2025 Chair of the Ligue Nationale Contre le Cancer scientific committee Ile de France • Previous position(s) 2022-2023 President of the International Liver Cancer Association (ILCA) 2019-2024 Member of the FNRS committee for physiology and Cancer 2012-2016 Chair of the national Inserm scientific committee for Cancer, Genetics and Bioinformatics 2020-2022 Chair of the Foundation ARC Committee for Research Orientation 2004-2009 Inserm Director of Research (DR2->DR1), Paris 1998-2004 Inserm Research Scientist (CR1), Paris • Editorial activities JHEP Reports new OA journal EASL, Geneva 2018 2023 Editor-in-Chief (IF 2022=9.9) Journal of Hepatology, EASL, Geneva 2014 2019 Senior Editor JHEP (IF 2022=30) Journal of Hepatology, EASL, Geneva 2010 2014 Associate Editor JHEP (IF 2014=10) • Prizes and Awards 1993 French academy of science, Award Eugène et Amélie Dupuis 1998 Award young researcher Ligue Nationale Contre le Cancer 2004 French Academy of Science, Award René Turpin for cancer research 2012 Award Inserm Research 2014 Elected fellow of the European Academy of Cancer Sciences 2015 Award Charles Oberling 2016 « Coups d’élan » Fondation Schueller-Bettencourt 2018 René et André Duquesne, Comité de Paris Ligue Contre le Cancer 2018 Chevalier de la Légion d’honneur 2019 Ismar Boas Medal, Germany 2019 Docteur Honoris Causa Université Catholique de Louvain 2021-2025 Awarded by Clarivate “most highly cited researcher” 2021 French Academy of Medicine, Albert 1er de Monaco Award 2024 Lucie Bolte Prize, Hannover, Germany 2025 EASL European Association for study of the Liver: Recognition award, Amsterdam • Invited lectures More than 260 invited lectures at international meetings (EACR keynote speaker 2024, AACR, ASCO GI, EASL, AASLD, EMBO, FASEB, Keystone, Falk symposium, Leopoldina symposium, CRCL, APASL, Forbeck Forum,... ) or international institutes and universities (Mayo Clinic, Mount Sinai NY, Yale, Rockefeller NY Univ, NIH-NCI, NCC Singapore, UCLondon, Frukfurt univ, Newcastle Univ, CNIO, Asan Hospital, Taiwan Univ, Tel Aviv Univ, Scripps…) • Reviewer for >50 journals including Nature, Nature Medicine, Nature Genetics, Nature Review Cancer, Nature Communications, Cell, Cancer Cell, Cancer Discovery, Lancet, Lancet Oncology, Clinical Cancer Research, Gastroenterology, Gut, Hepatology, JAMA, Journal of Clinical Investigation, Journal of Clinical Oncology, Journal of Experimental Medicine, Journal of Hepatology, PNAS, Science Translational Medicine. • Teaching activities and mentoring Member or chair of jury for ~60 PhD or HDR jury committees between 2002 and 2024 Between 1997 and 2024, supervision of 18 post-doctorates, 26 PhD students, and 21 master Students. Among them, ~30 are researchers in university laboratories and/or hospitals, ~8 are researchers in private companies. • Co-organizer of international scientific conferences including ILCA annual meetings 2015-2023 (400 to 900 participants each year); French-NTU symposium, Taiwan 2024; Holistic integrative Oncology, China 2024; EASL symposium 2024; AACR symposium 2022; EASL Basic Science Course 2020; Vice-Chair and chair of the Steering committee of the SIG neoplasm at AASLD 2019-2021 organization of several symposia (American Association for Study of liver disease); 5th International Conference on Liver and Cardiovascular Science, Wuhan, China, April 2019; HCC Summit EASL 2019; Cold Spring Harbor Asia liver metabolism and cancer, April 2016, Suzhou, China; Gilles Thomas’ symposium 2015 et 2017; FASEB Liver Summer Conference 2012

Organizations

Career arc: 2009 - 2026
Source: PubMed

Assistance Publique – Hôpitaux de Paris

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 420

Citations

Citations: 52 572 1st author: 9 Last author: 129 Unique author: 6

Main journals

J Hepatol 92
Hepatology 44
Gastroenterology 15
Cancer Res 14
Clin Cancer Res 10

Best Journals

J Hepatol 10
Nature 6
Ann Oncol 5

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clonal origin and early lineage divergence in adenosquamous carcinoma.
cells, carcinoma, adenosquamous, biological science disciplines, uterine cervical neoplasms, neoplasms		Cell Rep20260
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypes.
classification, mutation		Nat Commun20260
Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastoma.
cells, genes, chromosomes, human, pair 18, blood, neoplasms, liver, liver neoplasms, carcinogenesis, chromosome aberrations, blood cells, hepatoblastoma, chromosomes, evolution, molecular		JHEP Rep20260
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma.
cells, angiogenesis inhibitors, neoplasms, nephrectomy, classification, metastasectomy, predictive value of tests, carcinoma, renal cell, therapeutics, tissues, tumor microenvironment, rna, angiogenesis		Cancer Res Commun20260
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).
liver diseases, cells, carcinoma, hepatocellular, neoplasms, immunotherapy, nivolumab, electroporation		Hepatology20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 2 2

By status:

Completed 2
Active not recruiting 1
Terminated 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS